Dr Tony Dhillon

University of Surrey and Royal Surrey County Hospital

Consultant medical oncologist and Senior Lecturer at the Royal Surrey and University of Surrey. Specialising in colon, liver, pancreas and biliary cancers. Research interests are in colon cancer immunotherapy and microbiome and pancreatic and colon cancer. Research collaborations with the Royal Marsden/Institute of Cancer Research and the University of Oxford. I am the chief investigator of the POLEM trial- phase 3 study of immunotherapy in MSI-High stage 3 Colon cancer.

dont miss

Immunotherapy and Colon Cancer

Discussion of the evidence of benefit of checkpoint inhibition in colon cancer, in particular in the adjuvant setting- discussing on going clinical trials and up to date data. Description of data in metastatic colon cancer and future directions


  • Professor Robert Thomas: Speaking at the Oncology Convention

    Professor Robert Thomas
    Bedford and Addenbrooke's Cambridge University Hospitals

    Evidence based lifestyle strategies after cancer - a research review

  • Professor Noel Clarke: Speaking at the Oncology Convention

    Professor Noel Clarke
    The Christie and Salford Royal Hospitals, Manchester UK

    Improving Prostate Cancer Outcomes Through Cancer Trials

  • Professor Jayant Vaidya: Speaking at the Oncology Convention

    Professor Jayant Vaidya
    University College London

    Targeted intraoperative radiotherapy (TARGIT-IORT) for breast cancer

  • Dr Abeer Shabaan: Speaking at the Oncology Convention

    Dr Abeer Shabaan
    Queen Elizabeth Hospital Birmingham & University of Birmingham

    Breast Pathology: Assessing tumour response to neoadjuvant chemotherapy and endocrine therapy– Pathological considerations

  • Prantik Das: Speaking at the Oncology Convention

    Prantik Das
    University Hospital of Derby and Burton NHS Foundation Trust

    The Changing Landscape of Prostate Radiotherapy